Jyothy Labs approves ₹1,470 crore share buyback at ₹215 per share

Jyothy Labs Limited’s Board of Directors has approved a proposal to buy back up to 68,37,210 fully paid-up equity shares. The buyback will be conducted through the tender offer route at a price of ₹215 per equity share, aggregating up to ₹147 crore. This initiative represents 1.86% of the company’s total paid-up equity share capital as of March 31, 2026. The record date for determining entitlement to participate in the buyback has been set for November 11, 2026.

Jyothy Labs Announces Share Buyback

At a Board Meeting held on November 4, 2026, Jyothy Labs Limited approved a significant share buyback program. The company plans to repurchase up to 68,37,210 equity shares of face value ₹1 each. This buyback represents 1.86% of the company’s total paid-up equity share capital as of March 31, 2026.

Buyback Details and Pricing

The buyback will be executed through the tender offer route. The proposed buyback price is fixed at ₹215 per equity share, payable in cash. The aggregate amount for the buyback is set at a maximum of ₹147,00,00,150 (₹147 crore), excluding transactional costs such as brokerage and taxes. The company has appointed November 11, 2026, as the record date to ascertain the eligibility of shareholders for the buyback.

Promoter Participation

Notably, the promoter and promoter group of Jyothy Labs have indicated their intention not to participate in this buyback program, as communicated via a letter dated November 4, 2026.

Financial Results

In addition to the buyback approval, the Board also considered and approved the Unaudited Financial Results and Statements for the quarter and half-year ended September 30, 2026. The results were accompanied by a Limited Review Report from the company’s Statutory Auditors.

Source: BSE

Previous Article

Marksans Pharma posts record quarterly revenue of ₹940 crore

Next Article

Dr Lal PathLabs approves Q2 2026 financials and declares interim dividend